Autoantibodies to the β1-adrenoceptor from patients with periodontitis as a risk factor for cardiac dysfunction

ISRN Dentistry

Volumn 2011, Issue , 2011, Pages 1DUMMY-

  Segovia, Marcela ^a   Reina, Silvia ^a,b   Borda, Enri ^a,b   Sterin Borda, Leonor ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b CONICET ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CHOLESTEROL; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; ISOPRENALINE; LOW DENSITY LIPOPROTEIN; PARTIAL AGONIST;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HEART MUSCLE CONTRACTILITY; HEART RATE VARIABILITY; HUMAN; MALE; NONHUMAN; PERIODONTITIS; RAT; RISK FACTOR; SYMPATHETIC TONE;

EID: 84983573795     PISSN: 20904371     EISSN: 2090438X     Source Type: Journal    
DOI: 10.5402/2011/791393     Document Type: Article

References (30)

1. K. Karnoutsos, P. Papastergiou, S. Stefanidis, and A. Vakaloudi, "Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies," Hippokratia, vol. 12, no. 3, pp. 144-149, 2008.
2. T. Nakajima and K. Yamazaki, "Periodontal disease and risk of atherosclerotic coronary heart disease," Odontology, vol. 97, no. 2, pp. 84-91, 2009.
3. L. L. Humphrey, R. Fu, D. I. Buckley, M. Freeman, and M. Helfand, "Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis," Journal of General Internal Medicine, vol. 23, no. 12, pp. 2079-2086, 2008.
4. H. Toker, I. Marakoglu, and O. Poyraz, "Effect of meloxicam on gingival crevicular fluid IL-1beta and IL1 receptor antagonist levels in subjects with chronic periodontitis, and its effects on clinical parameters," Clinical Oral Investigations, vol. 10, no. 4, pp. 305-310, 2006.
5. M. A. Listgarten and P. M. Loomer, "Microbial identification in the management of periodontal diseases. A systematic review," Annals of Periodontology, vol. 8, no. 1, pp. 182-192, 2003.
6. J. Gamonal, A. Acevedo, A. Bascones, O. Jorge, and A. Silva, "Levels of interleukin-1β, -8, and -10 and RANTES in gingnival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment," Journal of Periodontology, vol. 71, no. 10, pp. 1535-1545, 2000.
7. A. Holmlund, L. Hänström, and U. H. Lerner, "Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease," Journal of Clinical Periodontology, vol. 31, no. 6, pp. 475-482, 2004.
8. P. A. Heasman, J. G. Collins, and S. Offenbacher, "Changes in crevicular fluid levels of interleukin-1 beta, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor alpha in experimental gingivitis in humans," Journal of Periodontal Research, vol. 28, no. 4, pp. 241-247, 1993.
9. I. B. Lamster, R. L. Oshrain, R. S. Celenti, J. B. Fine, and J. T. Grbic, "Indicators of the acute inflammatory and humoral immune responses in gingival crevicular fluid: relationship to active periodontal disease," Journal of Periodontal Research, vol. 26, no. 3, pp. 261-263, 1991.
10. E. Hernichel-Gorbach, K. S. Kornman, S. C. Holt et al., "Host responses in patients with generalized refractory periodontitis," Journal of Periodontology, vol. 65, no. 1, pp. 8-16, 1994.
11. C. A. Ramseier, J. S. Kinney, A. E. Herr et al., "Identification of pathogen and host-response markers correlated with periodontal disease," Journal of Periodontology, vol. 80, no. 3, pp. 436-446, 2009.
12. H. A. Schenkein, "Host responses in maintaining periodontal health and determining periodontal disease," Periodontology 2000, vol. 40, no. 1, pp. 77-93, 2006.
13. C. G. Dileep Sharma and A. R. Pradeep, "Anti-neutrophil cytoplasmis autoantibodies: a renewed paradigm in periodontal disease pathogenesis?" Journal of Periodontology, vol. 77, no. 8, pp. 1304-1313, 2006.
14. P. S. Rajapakse and A. E. Dolby, "Evidence for local production of antibodies to auto and non-self antigens in periodontal disease," Oral Diseases, vol. 10, no. 2, pp. 99-105, 2004.
15. L. A. De-Gennaro, J. D. Lopes, and M. Mariano, "Autoantibodies directed to extracellular matrix components in patients with different clinical forms of periodontitis," Journal of Periodontology, vol. 77, no. 12, pp. 2025-2030, 2006.
16. L. Sterin-Borda, C. Furlan, and E. Borda, "Circulating beta 1 adrenergic auto antibodies from patients with chronic periodontitis interact with gingival fibroblasts," European Journal of Dentistry, vol. 3, pp. 191-199, 2009.
17. L. Sterin-Borda, C. Furlan, and E. Borda, "Autoantibodies to β1-adrenoceptors in human chronic periodontitis induce overexpression of fibroblast CD40 and trigger prostaglandin E2 generation," Journal of Periodontal Research, vol. 44, no. 3, pp. 330-337, 2009.
18. L. Sterin-Borda, G. Gorelik, M. Postan, S. Gonzalez Cappa, and E. Borda, "Alterations in cardiac beta-adrenergic receptors in chagasic mice and their association with circulating beta-adrenoceptor-related autoantibodies," Cardiovascular Research, vol. 4, no. 4, pp. 116-125, 1970.
19. 1-adrenergic receptor and modifies myocardial contractile activity," Molecular and Biochemical Parasitology, vol. 127, no. 2, pp. 169-177, 2003.
20. L. Sterin-Borda and E. Borda, "Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia," Annals of the New York Academy of Sciences, vol. 917, pp. 273-280, 2000.
21. E. Borda, J. Pascual, and P. Cossio, "A circulating IgG in Chagas' disease which binds to β-adrenoceptors of myocardium and modulates their activity," Clinical and Experimental Immunology, vol. 57, no. 3, pp. 679-686, 1984.
22. C. J. Limas, I. F. Goldenberg, and C. Limas, "Autoantibodies against β-adrenoceptors in human idiopathic dilated cardiomyopathy," Circulation Research, vol. 64, no. 1, pp. 97-103, 1989.
23. W. Nesse, P. U. Dijkstra, F. Abbas et al., "Increased prevalence of cardiovascular and autoimmune diseases in periodontitis patients: a cross-sectional study," Journal of Periodontology, vol. 81, no. 11, pp. 1622-1628, 2010.
24. G. R. Persson and R. E. Persson, "Cardiovascular disease and periodontitis: an update on the associations and risk," Journal of Clinical Periodontology, vol. 35, no. 8, pp. 362-379, 2008.
25. B. Silke and J. G. Riddell, "Heart rate variability effects of an agonist or antagonists of the β-adrenoceptor assessed with scatterplot and sequence analysis," Clinical Autonomic Research, vol. 8, no. 3, pp. 145-153, 1998.
26. J. R. Jasper, R. E. Link, A. J. Chruscinski, B. K. Kobika, and B. Berstein, "Primary structure of the mouse β1-adrenergic receptor gene," Biochimica et Biophysica Acta, vol. 178, pp. 307-309, 1993.
27. M. L. X. Fu, W. Schulze, G. Wallukat, A. Hjalmarson, and J. Hoebeke, "Functional epitope analysis of the second extracellular loop of the human heart muscarinic acetylcholine receptor," Journal of Molecular and Cellular Cardiology, vol. 27, no. 1, pp. 427-436, 1995.
28. D. Feldman, T. S. Elton, D. M. Menachemi, and R. K. Wexler, "Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine," Vascular Health and Risk Management, vol. 6, pp. 387-397, 2010.
29. L. Sterin-Borda, A. Genaro, C. P. Leiros, G. Cremaschi, A. V. Echagüe, and E. Borda, "Role of nitric oxide in cardiac β-adrenoceptor-inotropic response," Cellular Signalling, vol. 10, no. 4, pp. 253-257, 1998.
30. M. J. De Jong and D. C. Randall, "Heart rate variability analysis in the assessment of autonomic function in heart failure," The Journal of Cardiovascular Nursing, vol. 20, no. 3, pp. 186-197, 2005.